GlassScriptPhysician profile
Amber Parler
NPI 1720609548
$2,787.64
in general payments reported to CMS, 2019-2025
19 companies · $792 in 2025
The $792 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.11 · 2022: $706 · 2023: $604 · 2024: $596 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $733.46 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $311.05 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $274.72 | 2023-2025 | |
| Janssen Biotech, INC. | $262.10 | 2021-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $203.05 | 2023-2025 | Zoryve |
| Organon LLC | $186.20 | 2025 | Nexplanon, Vtama |
| Pfizer INC. | $158.19 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $140.91 | 2023-2025 | Winlevi, Absorica Ld |
| Leo Pharma INC. | $108.93 | 2021-2025 | Anzupgo |
| Galderma Laboratories, L.P. | $80.86 | 2024-2025 | Nemluvio |
| Organogenesis INC. | $79.93 | 2024 | Affinity |
| Biofrontera INC. | $48.79 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.69 | 2024-2025 | Cabtreo, Targretin, Duobrii |
| Epi Health, LLC | $34.51 | 2022 | |
| Botanix Sb INC | $31.97 | 2025 | Sofdra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $26.79 | 2024 | Bimzelx |
| Amgen INC. | $24.91 | 2024 | Otezla |
| Kyowa Kirin, INC. | $20.97 | 2025 | |
| Dermavant Sciences, INC. | $18.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Parler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.